Lv1
10 积分 2024-08-26 加入
Journavx (suzetrigine)
3个月前
已完结
Selective Inhibition of Na V 1.8 with VX-548 for Acute Pain
3个月前
已完结
Chemical strategies for brain delivery of genomic therapy
3个月前
已完结
A Phase II, multicentric, randomized, double-blind, placebo controlled, proof of concept study of efficacy and safety of Rifamycin SV-MMX® 600 mg tablets administered three or two times daily to patients with diarrhea-predominant irritable bowel syndrome (IBS-D)
5个月前
已关闭
MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations
5个月前
已完结
Budding Multi-matrix Technology—a Retrospective Approach, Deep Insights, and Future Perspectives
6个月前
已完结
皖公网安备34019202002308
